CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

By Shengyong Yin, Jinjun Li, Chen Hu, Xinhua Chen, M. Yao, Ming-xia Yan, G. Jiang, Chao Ge, Haiyang Xie, D. Wan and 3 more. International Journal of Cancer, 2007

601 citations recorded by the source corpus.

Subfields: Oncology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/7fd694ef8b0a56e79836f363911ce0cc8cd2f5f6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. A. Puisieux
2. R. Weinberg

Citations in the corpus

• Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition (2008, background): “Over the past few years, candidate cancer stem cells have been identified in a variety of human malignancies including leukemias and a number of solid tumors such as glioblastomas, medulloblastomas and carcinomas [11–24].”
• CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway (2008, background): “Further, CD133 represents only a minority of the tumor cell population in human HCC specimens (Suetsugu et al., 2006; Ma et al., 2007; Yin et al., 2007).”